Evoke Wealth’s GSK GSK Stock Holding History

Evoke Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	3,962 -433	-10%	-$23.5K	﹤0.01%	634
2025 Q4	$217K	Buy	+4,395	New	+$205K	﹤0.01%	611
2022 Q4	–	Sell	-584	Closed	-$17K	–	694
2022 Q3	$17K	Hold	584	–	–	﹤0.01%	665
2022 Q2	$32K	Hold	584	–	–	﹤0.01%	581
2022 Q1	$32K	Hold	584	–	–	﹤0.01%	580
2021 Q4	$33K	Hold	584	–	–	﹤0.01%	592
2021 Q3	$28K	Hold	584	–	–	﹤0.01%	581
2021 Q2	$29K	Hold	584	–	–	﹤0.01%	585
2021 Q1	$26K	Buy	584 +353	+153%	+$16K	﹤0.01%	542
2020 Q4	$11K	Hold	231	–	–	﹤0.01%	573
2020 Q3	$11K	Buy	231 +216	+1,440%	+$10.8K	﹤0.01%	547
2020 Q2	$1K	Buy	15 +8	+114%	+$410	﹤0.01%	971
2020 Q1	$363	Sell	7 -2,938	-100%	-$157K	﹤0.01%	1048
2019 Q4	$177K	Buy	2,945 +4	+0.1%	+$222	0.02%	241
2019 Q3	$159K	Buy	+2,941	New	+$151K	0.02%	299

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Evoke Wealth's GSK Position: Q1 2026 in Review

Evoke Wealth reduced its GSK (GSK) stake by 9.9% in Q1 2026, selling an estimated $23.5K and leaving 3,962 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #634.

Evoke Wealth first reported a position in GSK in Q3 2019 and has held it in 15 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Evoke Wealth held 3,962 shares of GSK worth $220K as of Q1 2026.
Evoke Wealth sold 433 GSK shares in Q1 2026, an estimated $23.5K.
GSK made up ﹤0.01% of Evoke Wealth's portfolio in Q1 2026, its #634 holding.
Evoke Wealth first reported a position in GSK in Q3 2019 and has held it in 15 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.